DURECT Competitors
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside | Analysts | Market Cap |
---|---|---|---|---|---|---|---|---|---|
PFE | Pfizer | Outperform |
2
|
$28.64 | Buy/Sell | $32.87 | 6.49% | 6 | $162.29B |
TEVA | Teva Pharmaceutical Industries | Outperform |
12
|
$16.29 | Buy/Sell | $11.59 | 4.36% | 9 | $18.45B |
VTRS | Viatris Inc | Hold |
8
|
$10.98 | Buy/Sell | $11.73 | 9.29% | 5 | $13.32B |
SUPN | Supernus Pharmaceuticals | Outperform |
16
|
$29.10 | Buy/Sell | $41.00 | 40.89% | 0 | $1.72B |
COPN | Cosmo Pharmaceuticals N.V. | Buy |
12
|
CHF72.90 | Buy/Sell | CHF76.55 | 28.34% | 0 | CHF1.14B |
COLL | Collegium Pharmaceutical | Outperform |
11
|
$32.47 | Buy/Sell | $37.75 | 23.19% | 1 | $1.24B |
ZVRA | Zevra Therapeutics | Buy |
10
|
$4.73 | Buy/Sell | $19.50 | 291.12% | 1 | $204.66M |
CPIX | Cumberland Pharmaceuticals | - |
0
|
$2.03 | Buy/Sell | $8.50 | -100.00% | 0 | $24.38M |
ACRX | AcelRx Pharmaceuticals | Outperform |
6
|
$1.08 | Buy/Sell | $4.63 | 293.52% | 0 | $17.33M |
DMK | DMK Pharmaceuticals | - |
8
|
$0.03 | Buy/Sell | $1.50 | -100.00% | 0 | $0.35M |